FDA Inspection
Tarmac Products, Inc.Tarmac Products, Inc. – FDA Inspection, Feb 6, 2026
Record Details
This FDA Inspection record concerns Tarmac Products, Inc., with an inspection on February 6, 2026, issued by the Florida District Office, covering human drugs.
View Company Profile
ID · 82b0089d-8e25-4a45-9dec-cf416fa5e26b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1301824
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.111Establishment of time limitations
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.46(b)Equipment for Environmental Control
- 21 CFR 211.84(d)(2)Component identification test
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Tarmac Products, Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| November 4, 2025 | VAI | Florida District Office | Compliance: Medical Devices |
| July 22, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 10, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 8, 2015 | VAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
Other documents for Tarmac Products, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.